How psychotherapy changes the brain: Understanding the mechanisms

Psychiatric Times

Volumn 28, Issue 8, 2011, Pages 21-23

  Karlsson, Hasse ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052043205     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gabbard GO. A neurobiologically informed perspective on psychotherapy. Br J Psychiatry. 2000; 177:117-122. (Pubitemid 30624822)
2. Kandei ER. A new intellectual framework for psychiatry. Am J Psychiatry. 1998;155:457-469.
3. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psy-chiatry. 2001;58:631-640. (Pubitemid 32640857)
4. Martin SD, Martin E, Rai SS, et al. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochoride: preliminary findings. Arch Gen Psychiatry. 2001 ;58: 641-648. (Pubitemid 32640858)
5. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61:34-41. (Pubitemid 38044639)
6. Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry, 1992;49:681-689.
7. Nakatani E, Nakgawa A, Ohara Y, et al. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res. 2003;124:113-120. (Pubitemid 38366260)
8. Schwartz JM, Stoessel PW, Baxter LR, et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:109-113. (Pubitemid 26049387)
9. Praško J, Horácek J, Zálesky R, et al. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett 2004;25:340-348.
10. Beutel ME, Stark R, Pan H, et al. Changes of brain activation prepost short-term psychodynamic inpatient psychotherapy: an fMRI study of panic disorder patients. Psychiatry Res. 2010;184:96-104.
11. FurmarkT, Tillfors M, Marteinsdottir I, et al. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry. 2002;59: 425-433. (Pubitemid 34477677)
12. Paquette V, Levesque J, Mensour B, et al. "Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage. 2003;18:401-409. (Pubitemid 36269149)
13. Straube T, Glauer M, Oilger S, et al. Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage. 2006;29:125-135. (Pubitemid 41828037)
14. Felmingham K, Kemp A, Williams L, et al. Changes in anterior cingulate and amygdala after cognitive behavior therapy of posttraumatic stress. Psychol Sci. 2007;18:127-129.
15. Schnell K, Herpertz SC. Effects of dialectic-behavioral-therapy on the neural correlates of affective hyperarousal in borderline personality disorder. J Psychiatr Res. 2007;41:837-847. (Pubitemid 46693898)
16. Lai C, Daini S, Calcagni ML, et al. Neural correlates of psychodynamic psychotherapy in borderline disorders-a pilot investigation. Psychother Psycho-som. 2007;76:403-405. (Pubitemid 47530560)
17. Karlsson H, Hirvonen J, Kajander J, et al. Research letter: psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder. Psychol Med. 2010;40:523-528.
18. Frewen PA, Dozois DJ, Lanius PA Neuroimaging studies of psychological interventions for mood and anxiety disorders: empirical and methodological review. Clin Psychol Rev. 2008;28:228-246.
19. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neuro-sci. 2008;9:788-796.
20. Lehto SM, Tolmunen T, Joensuu M, et al. Changes in midbrain serotonin transporter availability in atyp-ically depressed subjects after one year of psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:229-237.
21. Hirvonen J, Hietala J, Kajander J, et al. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclo-pride PET. J Psychopharmacol. 2010 Sep 9; [Epub ahead of print].
22. Drevets WC, Frank E, Price JC, et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry. 1999;46:1375-1387.
23. Sargent PA, Kjaer KH, Bench CJ, et al. Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry. 2000;57:174-180. (Pubitemid 30075269)
24. Bhagwagar Z, Wylezinska M, Taylor M, et al. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry. 2004;161:368-370. (Pubitemid 38419291)
25. Meltzer CC, Price JC, Mathis CA, et al. Serotonin 1A receptor binding and treatment response in latedepression. Neuropsychopharmacology. 2004; 29:2258-2265. (Pubitemid 39578918)
26. Parsey RV, Oquendo MA, Ogden RT, et al. Altered serotonin 1A binding in major depression: a [car-bonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry. 2006;59:106-113. (Pubitemid 43117499)
27. Moses-Kolko EL, Wisner KL, Price JC, et al. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Stent. 2008;89:685-692. (Pubitemid 351335035)
28. Hollon SD, Jarrett RB, Nierenberg AA, et al. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry. 2005; 66:455-468. (Pubitemid 40593574)
29. Nakao T, Nakagawa A, Yoshiura T, et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry. 2005;57:901-910. (Pubitemid 40488359)
30. Sakai Y, Kumano H, Nishikawa M, et al. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage. 2006;33:218-226. (Pubitemid 44397589)
31. Apostolova I, Block S, Buchert R, et al. Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorders as assessed by brain FDG-PET. Psychiatry Res.2010;184:105-116.